555
Views
25
CrossRef citations to date
0
Altmetric
Reviews

Pharmacokinetics and pharmacodynamics of antimicrobial drugs

, MD, , MD, , MD & , MD
Pages 475-487 | Published online: 06 May 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

T. Mazzei. (2010) The Pharmacokinetics and Pharmacodynamics of the Carbapenems: Focus on Doripenem. Journal of Chemotherapy 22:4, pages 219-225.
Read now

Articles from other publishers (24)

Hamid Teimouri & Anatoly B. Kolomeisky. (2022) Power of stochastic kinetic models: From biological signaling and antibiotic activities to T cell activation and cancer initiation dynamics. WIREs Computational Molecular Science 12:6.
Crossref
Bruna Menezes, Izabel Alves, Keli Staudt, Betina Beltrame, Lessandra Michelin, Bibiana Verlindo de Araújo & Leandro Tasso. (2021) PK/PD modeling of daptomycin against MRSA and MRSE and Monte Carlo simulation for bacteremia treatment. Brazilian Journal of Microbiology 52:4, pages 1967-1979.
Crossref
Muhammad Kashif Maan, Tamoor Hamid Chaudhry, Adeel Sattar, Muhammad Abu Bakr Shabbir, Saeed Ahmed, Kun Mi, Waqas Ahmed, Shuyu Xie, Li Xin & Lingli Huang. (2021) Dose Optimization of Aditoprim-Sulfamethoxazole Combinations Against Trueperella pyogenes From Patients With Clinical Endometritis by Using Semi-mechanistic PK/PD Model. Frontiers in Pharmacology 12.
Crossref
Ahmed O. El-Gendy, Ahmed Samir, Esraa Ahmed, Chukuka S. Enwemeka & Tarek Mohamed. (2021) The antimicrobial effect of 400 nm femtosecond laser and silver nanoparticles on gram-positive and gram-negative bacteria. Journal of Photochemistry and Photobiology B: Biology 223, pages 112300.
Crossref
Ken Nguyen, Timothy J. Bensman, Xiaohui (Tracey) Wei & Jason N. Moore. (2020) Semimechanistic Modeling of Eravacycline Pharmacodynamics Using In Vitro Time-Kill Data with MIC Incorporated in an Adaptive Resistance Function . Antimicrobial Agents and Chemotherapy 64:9.
Crossref
Jessica R Salas, Majid Jaberi-Douraki, Xuesong Wen & Victoriya V Volkova. (2020) Mathematical modeling of the ‘inoculum effect': six applicable models and the MIC advancement point concept. FEMS Microbiology Letters 367:5.
Crossref
Christian Bustamante, Rodrigo Ochoa, Claudia Asela & Carlos Muskus. (2019) Repurposing of known drugs for leishmaniasis treatment using bioinformatic predictions, in vitro validations and pharmacokinetic simulations. Journal of Computer-Aided Molecular Design 33:9, pages 845-854.
Crossref
Hamid Teimouri & Anatoly B. Kolomeisky. (2019) Theoretical investigation of stochastic clearance of bacteria: first-passage analysis. Journal of The Royal Society Interface 16:152, pages 20180765.
Crossref
Jessica Coates, Bo Ryoung Park, Dai Le, Emrah Şimşek, Waqas Chaudhry & Minsu Kim. (2018) Antibiotic-induced population fluctuations and stochastic clearance of bacteria. eLife 7.
Crossref
Yoshiaki Kitamura. (2018) Considerations regarding PK/PD theory for antibiotics treatment from a pharmacokinetic perspective抗菌薬のPK/PDに関する薬物動態学的視点からの考察. Drug Delivery System 33:1, pages 10-17.
Crossref
Jun Li, Shuyu Xie, Saeed Ahmed, Funan Wang, Yufeng Gu, Chaonan Zhang, Ximan Chai, Yalan Wu, Jinxia Cai & Guyue Cheng. (2017) Antimicrobial Activity and Resistance: Influencing Factors. Frontiers in Pharmacology 8.
Crossref
David Czock, Martino Spitaletta & Frieder Keller. (2015) Suboptimal antimicrobial drug exposure in patients with renal impairment. International Journal of Clinical Pharmacy 37:5, pages 906-916.
Crossref
Tomas Radivoyevitch, Nopphon Siranart, Lynn Hlatky & Rainer Sachs. (2015) Stochastic Process Pharmacodynamics: Dose Timing in Neonatal Gentamicin Therapy as an Example. The AAPS Journal 17:2, pages 447-456.
Crossref
Simona Constantinescu, Shana J. Sturla, Giancarlo Marra, Bernd Wollscheid & Niko Beerenwinkel. 2015. Computational Systems Toxicology. Computational Systems Toxicology 371 392 .
Karsten Theophel, Veronika J. Schacht, Michael Schlüter, Sylvia Schnell, Catalina-Suzana Stingu, Reiner Schaumann & Michael Bunge. (2014) The importance of growth kinetic analysis in determining bacterial susceptibility against antibiotics and silver nanoparticles. Frontiers in Microbiology 5.
Crossref
Yoshiaki Kitamura, Kenta Yoshida, Makiko Kusama & Yuichi Sugiyama. (2014) A Proposal of a Pharmacokinetic/pharmacodynamic (PK/PD) Index Map for Selecting an Optimal PK/PD Index from Conventional Indices (AUC/MIC, Cmax/MIC, and TAM) for Antibiotics. Drug Metabolism and Pharmacokinetics 29:6, pages 455-462.
Crossref
N. Notkina, C. Dahyot-Fizelier & A.K. Gupta. (2012) In vivo microdialysis in pharmacological studies of antibacterial agents in the brain. British Journal of Anaesthesia 109:2, pages 155-160.
Crossref
T. Grünewald & B.R. Ruf. (2012) Muskuloskelettale Infektionen im Zeitalter multiresistenter ErregerMusculoskeletal infections in the era of multiresistant pathogens. Der Unfallchirurg 115:6, pages 503-510.
Crossref
Sandhya Kortagere, Markus Lill & John Kerrigan. 2012. Computational Toxicology. Computational Toxicology 21 48 .
Rima A. Mohammad, Gregory A. Eschenauer & Gary R. Matzke. 2011. Textbook of Critical Care. Textbook of Critical Care 1294 1302 .
Harin A. Karunajeewa. 2012. Treatment and Prevention of Malaria. Treatment and Prevention of Malaria 157 190 .
Michael N. Gwynn, Alison Portnoy, Stephen F. Rittenhouse & David J. Payne. (2010) Challenges of antibacterial discovery revisited. Annals of the New York Academy of Sciences 1213:1, pages 5-19.
Crossref
Bertram Hartmann, David Czock & Frieder Keller. (2010) Drug Therapy in Patients With Chronic Renal Failure. Deutsches Ärzteblatt international.
Crossref
Sebastian Maus, Caecilia Holch, David Czock, Florian Thalhammer, Frieder Keller & Bertram Hartmann. (2010) Umfrage zur Arzneimitteldosierung bei Niereninsuffizienz unter nephrologisch tätigen ÄrztenQuestionnaire surveying nephrologists on drug dose adjustment in patients with impaired kidney function. Wiener klinische Wochenschrift 122:15-16, pages 479-485.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.